Healthy Leukopak
LeukoCore Healthy Leukopak product contains concentrated immune cells from donors with clinically confirmed Healthy, collected via apheresis. Ideal for matched controls and cell therapy manufacturing. Reserve a scheduled collection today.
| Lot # | Condition | Bag Size | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 75615 | Normal (Healthy) | Half Bag | Caucasian | 36 | Male | United States |
Vitamin B Fluoxetine Bupropion Minoxidil Raloxifene Estradiol 25mg of Seroquel most nights
|
2 | $5,367.00 | |
| 74075 | Normal (Healthy) | Half Bag | Caucasian | 29 | Female | United States |
Melatonin QD
|
2 | $5,367.00 | |
| 59323 | Normal (Healthy) | Half Bag | Caucasian Asian/Pacific Islander | 38 | Male | United States |
Vitamin B12 QW3
|
1 | $5,367.00 | |
| 59170 | Normal (Healthy) | Full Bag | Caucasian | 39 | Female | United States |
Evening primrose QD Vitamin D supplement PRN Fluoxetine 20mg
|
1 | $7,581.00 | |
| 56090 | Normal (Healthy) | Half Bag | Caucasian Hispanic/Latino | 50 | Male | United States | 1 | $5,367.00 | ||
| 56021 | Normal (Healthy) | Hispanic/Latino | 40 | Male | United States |
No meds or supp
|
2 | |||
| 55994 | Normal (Healthy) | Half Bag | Hispanic/Latino | 31 | Female | United States |
Iron QD Vitamin B12 QD Vitamin C QD Collagen QD
|
2 | $5,367.00 | |
| 59323 | Normal (Healthy) | Half Bag | Caucasian Asian/Pacific Islander | 38 | Male | United States |
Vitamin B12 QW3
|
3 | $5,367.00 | |
| 59170 | Normal (Healthy) | Full Bag | Caucasian | 39 | Female | United States |
Evening primrose QD Vitamin D supplement PRN Fluoxetine 20mg
|
3 | $7,581.00 |
High-Yield LeukoCore Healthy Leukopak for Immunology Research
LeukoCore Healthy Leukopak is collected from healthy donors through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research for matched controls.
Product Features
- Research Use Only (RUO) human leukopaks
- Clinically confirmed healthy donors
- High cell yield for large-scale studies
- Processed and shipped within 24 hours of collection
- Fresh or cryopreserved options available
- IRB-approved and ethically sourced
- Infectious disease testing
- HLA-A typing
- Screen donors with LeukoLot™
De-identified Donor Data
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported medication history and allergies
Applications
- Immune cell characterization in healthy controls
- Therapeutic development and screening
- Cell-based assays and cytokine profiling
- Multi-omics studies including single-cell sequencing
Compliance and Quality Assurance
- Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
- HIPAA-compliant handling of donor information
- Rigorous donor screening and documentation
Ordering & Customization
Healthy Leukopak is available fresh or cryopreserved. Need a disease-specific condition, or want to check current availability across our full leukopak inventory? Visit our human leukopak page to browse other disease-state options and live stock status. For international shipping or regulatory documentation, please contact learnmore@sanguinebio.com to confirm regional compliance and shipping availability.
Protocols & Documentation
-
Download
Leukopak Cryopreservation
Standard operating procedure for cryopreserving leukopak units with controlled freezing and post-thaw viability targets.
-
Download
Leukopak Thawing
Validated thawing workflow for cryopreserved leukopaks to maximize recovery while maintaining sterility and chain of custody.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Leukopak
Frequently Asked Questions
Ask a Question
Need a custom Leukopak cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.